Departments of Pediatrics and Population Health Sciences, UUniversity of Wisconsin School of Medicine and Public Health
Philip M. Farrell, MD, PhD is a neonatologist and pediatric pulmonologist at the University of Wisconsin in the Departments of Pediatrics and Population Health Sciences of the School of Medicine and Public Health. Dr. Farrell is also a former CF Center Director at the University of Wisconsin [with five decades of experience in the care of children with respiratory disorders and research on respiratory disorders of infants and children with a recent focus on cystic fibrosis, especially genetic aspects]. He has served as the director of the Wisconsin CF newborn screening study that has led the CDC and CFF to recommend universal screening to achieve routine early diagnosis of CF. His efforts to study CF newborn screening stemmed from experiences during the late 1970s while he was working concurrently as a neonatologist and CF Center Director and observing to his surprise better long term health in patients diagnosed early because of neonatal intestinal obstruction (meconium ileus) compared to infants who suffered from delayed recognition of CF.
Since 2006, he has served as the CF Foundation’s National Facilitator for Cystic Fibrosis Newborn Screening and Quality Improvement throughout the USA and an advisor to several other countries.
Dr. Farrell’s current research funded by four grants focuses on topics related to CF newborn screening: 1) nutritional and pulmonary outcomes after early diagnosis as related to variations in infant nutrition and genomic variants; and 2) the ancient origin of F508del-CF and its impact on the heterozygote selective advantage; and whole genome sequencing as an adjunct to newborn screening. He serves as co-PI of the FIRST project.
S05--Along the CFTR Spectrum: CF Off/On Modulators, CRMS/CF-SPID, COPD & CF Carriers
Thursday, October 23, 2025
2:30 PM - 4:30 PM PDT